Home  »  Finance   »  Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) Is An E...

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) Is An Exciting Stock

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) traded at $40.44 at close of the session on Tuesday, 01/24/23, made an upward move of 6.70% on its previous day’s price.

Looking at the stock we see that its previous close was $37.90 with the day’s price range being $37.2297 – $41.10. In terms of its 52-week price range, AMLX has a high of $39.78 and a low of $6.51. The company’s stock has gained about 13.76% over that past 30 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Amylyx Pharmaceuticals Inc. has a market cap of $2.51 billion and is expected to release its quarterly earnings report on Aug 11, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.97, with the EPS growth for the year raised at -$3.65 for 2022 and -$1.82 for next year. These figures represent 72.70% and 50.10% growth in EPS for the two years respectively.

According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $2.81 million, or 886.00% up from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AMLX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.

Looking further, we note the current price level is 11.79% off its SMA20 and 11.59% from its 50-day simple moving average. The RSI (14) is pointing at 63.83 while the volatility over the past week is 8.23% and jumps to 6.16% over the past one month.

Coming back to Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX), we note that the average 3-month trading volume was 775.45K, while that of the preceding 10-day period stands at 0.87 million. Current shares outstanding are 58.53 million.

The insiders hold 24.57% of the company’s shares while institutions hold 65.70%. The data shows that short shares as of Oct 13, 2022, stood at 6.7 million at a short ratio of 3.52. This represents a 11.44% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 3.68 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 9.45% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *